Emerg Infect Dis. 2021 Feb;27(2):348-351. doi: 10.3201/eid2702.203439.
An epidemic of dengue virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infections occurred in Argentina during 2020. We describe the clinical characteristics and outcomes in a cohort of patients hospitalized because of co-infection. We retrospectively identified 13 patients from different hospitals in Buenos Aires who had confirmed infection with SARS-CoV-2 and dengue virus and obtained clinical and laboratory data from clinical records. All patients had febrile disease when hospitalized. Headache was a common symptom. A total of 8 patients had respiratory symptoms, 5 had pneumonia, and 3 had rash. Nearly all patients had lymphopenia when hospitalized. No patients were admitted to an intensive care unit or died during follow up. Co-infection with SARS-CoV-2 and dengue virus can occur in patients living in areas in which both viruses are epidemic. The outcome of these patients did not seem to be worse than those having either SARS-CoV-2 or dengue infection alone.
2020 年,阿根廷同时爆发登革热病毒和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫情。我们描述了因合并感染而住院的患者队列的临床特征和结局。我们从布宜诺斯艾利斯不同医院回顾性地确定了 13 名同时感染 SARS-CoV-2 和登革热病毒的患者,并从临床记录中获得了临床和实验室数据。所有患者住院时均有发热性疾病。头痛是常见症状。共有 8 例患者有呼吸道症状,5 例有肺炎,3 例有皮疹。几乎所有患者住院时均有淋巴细胞减少症。在随访期间,没有患者入住重症监护病房或死亡。居住在同时流行这两种病毒的地区的患者可能会同时感染 SARS-CoV-2 和登革热病毒。这些患者的结局似乎并不比单独感染 SARS-CoV-2 或登革热病毒的患者更差。